Overview

Red Blood Cell Precursor Formulation to Determine Increased Production

Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to measure the change in hemoglobin levels after the administration of an amino acid based, RBC precursor formulation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Targeted Medical Pharma